Response to "Randomized controlled trial of remimazolam compared with placebo in Japanese patients undergoing upper gastrointestinal endoscopy: Phase III investigator-initiated clinical trial"

被引:1
|
作者
Park, Jae Yong [1 ]
机构
[1] Chung Ang Univ, Coll Med, Dept Internal Med, Seoul, South Korea
关键词
D O I
10.1111/den.14912
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Response to "Randomized controlled trial of remimazolam compared with placebo in Japanese patients undergoing upper gastrointestinal endoscopy: Phase III investigator-initiated clinical trial
    Ichijima, Ryoji
    Esaki, Mitsuru
    Ikehara, Hisatomo
    DIGESTIVE ENDOSCOPY, 2024,
  • [2] Randomized controlled trial of remimazolam compared with placebo in Japanese patients undergoing upper gastrointestinal endoscopy: Phase III investigator-initiated clinical trial
    Ichijima, Ryoji
    Ikehara, Hisatomo
    Yamaguchi, Daisuke
    Nagata, Yasuhiko
    Ogura, Kanako
    Esaki, Mitsuru
    Minoda, Yosuke
    Ono, Hiroyuki
    Maeda, Yuki
    Kiriyama, Shinsuke
    Sumiyoshi, Tetsuya
    Kanmura, Yuichi
    Gotoda, Takuji
    DIGESTIVE ENDOSCOPY, 2024,
  • [3] COMPARISON BETWEEN REMIMAZOLAM AND PLACEBO IN JAPANESE PATIENTS UNDERGOING COLONOSCOPY: A PHASE III, INVESTIGATOR-INITIATED, RANDOMIZED, CONTROLLED TRIAL
    Yamaguchi, Daisuke
    Ichijima, Ryoji
    Ikehara, Hisatomo
    Ono, Hiroyuki
    Hotta, Kinichi
    Esaki, Mitsuru
    Minoda, Yosuke
    Nagata, Yasuhiko
    Ogura, Kanako
    Kiriyama, Shinsuke
    Sumiyoshi, Tetsuya
    Kanmura, Yuichi
    GASTROINTESTINAL ENDOSCOPY, 2024, 99 (06) : AB613 - AB614
  • [4] First dose-ranging study of remimazolam in Japanese patients undergoing gastrointestinal endoscopy: Phase II investigator-initiated clinical trial
    Ichijima, Ryoji
    Ikehara, Hisatomo
    Maeda, Takeshi
    Sugita, Tomomi
    Horii, Toshiki
    Iwao, Aya
    Ogura, Kanako
    Kusano, Chika
    Kondo, Yuko
    Suzuki, Takahiro
    Gotoda, Takuji
    DIGESTIVE ENDOSCOPY, 2022, 34 (07) : 1403 - 1412
  • [5] EFFICACY AND SAFETY OF ADALIMUMAB IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS - AN INVESTIGATOR-INITIATED RANDOMIZED PLACEBO-CONTROLLED TRIAL
    Krabbe, S.
    Ostergaard, M.
    Sorensen, I. J.
    Jensen, B.
    Madsen, O. R.
    Eng, G. P.
    Asmussen, K. H.
    Moller, J.
    Balding, L.
    Pedersen, S. J.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 1131 - 1132
  • [6] Remimazolam tosilate in upper gastrointestinal endoscopy: A multicenter, randomized, non-inferiority, phase III trial
    Chen, Shao-Hui
    Yuan, Tang-Mi
    Zhang, Jiao
    Bai, Hua
    Tian, Ming
    Pan, Chu-Xiong
    Bao, Hong-Guang
    Jin, Xiao-Ju
    Ji, Fu-Hai
    Zhong, Tai-Di
    Wang, Qiang
    Lv, Jian-Rui
    Wang, Sheng
    Li, Yu-Juan
    Yu, Yong-Hao
    Luo, Ai-Lin
    Li, Xiang-Kui
    Min, Su
    Li, Lin
    Zou, Xiao-Hua
    Huang, Yu-Guang
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2021, 36 (02) : 474 - 481
  • [7] Rituximab plus leflunomide in rheumatoid arthritis: a randomized, placebo-controlled, investigator-initiated clinical trial (AMARA study)
    Behrens, Frank
    Koehm, Michaela
    Rossmanith, Tanja
    Alten, Rieke
    Aringer, Martin
    Backhaus, Marina
    Burmester, Gerd R.
    Feist, Eugen
    Herrmann, Eva
    Kellner, Herbert
    Krueger, Klaus
    Lehn, Annette
    Muller-Ladner, Ulf
    Rubbert-Roth, Andrea
    Tony, Hans-Peter
    Wassenberg, Siegfried
    Burkhardt, Harald
    RHEUMATOLOGY, 2021, 60 (11) : 5318 - 5328
  • [8] Effectiveness and safety of remimazolam tosilate versus propofol for sedation in patients undergoing gastrointestinal endoscopy: a randomized controlled trial
    Li, Dongbin
    Wang, Yu
    Xing, Yang
    Zhao, Zicen
    Chang, Liya
    Leng, Yufang
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2024, : 1371 - 1380
  • [9] Study design in investigator-initiated phase III clinical trial of L-arginine on MELAS
    Koga, Y.
    Akita, Y.
    Nishioka, J.
    Yatsuga, S.
    Katayama, K.
    Matsuishi, T.
    EUROPEAN JOURNAL OF NEUROLOGY, 2007, 14 : 244 - 244
  • [10] Effect of remimazolam vs propofol in high-risk patients undergoing upper gastrointestinal endoscopy: a non-inferiority randomized controlled trial
    Li, Zhi
    Yuan, Daming
    Yu, Yu
    Xu, Jie
    Yang, Weili
    Chen, Li
    Luo, Nanbo
    TRIALS, 2024, 25 (01)